Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/06
End: 06/30/08
Due: 06/30/09
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 01/31/08
Due: 01/31/09
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery | NCT00404014 | Allon Therapeutics | user2@example.com | None | 2006-08-31 | 2008-06-30 | 2009-06-30 | - | - | 2025-07-14 |
| Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy | NCT01110720 | Allon Therapeutics | user2@example.com | None | 2010-10-31 | 2012-12-31 | 2013-12-31 | - | - | 2025-07-14 |
| Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment | NCT00422981 | Allon Therapeutics | user2@example.com | None | 2007-01-31 | 2008-01-31 | 2009-01-31 | - | - | 2025-07-14 |